126 related articles for article (PubMed ID: 16819731)
1. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
[TBL] [Abstract][Full Text] [Related]
2. Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis.
Lei T; Zhao X; Jin S; Meng Q; Zhou H; Zhang M
Clin Genitourin Cancer; 2013 Mar; 11(1):56-62. PubMed ID: 22982111
[TBL] [Abstract][Full Text] [Related]
4. Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.
Orenes-Piñero E; Cortón M; González-Peramato P; Algaba F; Casal I; Serrano A; Sánchez-Carbayo M
J Proteome Res; 2007 Nov; 6(11):4440-8. PubMed ID: 17902641
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers.
Saito M; Kimoto M; Araki T; Shimada Y; Fujii R; Oofusa K; Hide M; Usui T; Yoshizato K
Eur Urol; 2005 Nov; 48(5):865-71. PubMed ID: 15964125
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
7. Stage-dependent increase of orosomucoid and zinc-alpha2-glycoprotein in urinary bladder cancer.
Irmak S; Tilki D; Heukeshoven J; Oliveira-Ferrer L; Friedrich M; Huland H; Ergün S
Proteomics; 2005 Nov; 5(16):4296-304. PubMed ID: 16196100
[TBL] [Abstract][Full Text] [Related]
8. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.
Kawanishi H; Matsui Y; Ito M; Watanabe J; Takahashi T; Nishizawa K; Nishiyama H; Kamoto T; Mikami Y; Tanaka Y; Jung G; Akiyama H; Nobumasa H; Guilford P; Reeve A; Okuno Y; Tsujimoto G; Nakamura E; Ogawa O
Clin Cancer Res; 2008 May; 14(9):2579-87. PubMed ID: 18451219
[TBL] [Abstract][Full Text] [Related]
9. Bikunin loss in urine as useful marker for bladder carcinoma.
Tsui KH; Tang P; Lin CY; Chang PL; Chang CH; Yung BY
J Urol; 2010 Jan; 183(1):339-44. PubMed ID: 19914646
[TBL] [Abstract][Full Text] [Related]
10. Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
Makridakis M; Roubelakis MG; Bitsika V; Dimuccio V; Samiotaki M; Kossida S; Panayotou G; Coleman J; Candiano G; Anagnou NP; Vlahou A
J Proteome Res; 2010 Jun; 9(6):3243-59. PubMed ID: 20423150
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the human urinary proteome by 1D SDS-PAGE and chip-HPLC-MS/MS identification of the AACT putative urinary biomarker.
Zhang Y; Li Y; Qiu F; Qiu Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3395-401. PubMed ID: 21093387
[TBL] [Abstract][Full Text] [Related]
12. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.
Tolson JP; Flad T; Gnau V; Dihazi H; Hennenlotter J; Beck A; Mueller GA; Kuczyk M; Mueller CA
Proteomics; 2006 Jan; 6(2):697-708. PubMed ID: 16252305
[TBL] [Abstract][Full Text] [Related]
13. Proteome analysis of responses to ascochlorin in a human osteosarcoma cell line by 2-D gel electrophoresis and MALDI-TOF MS.
Kang JH; Park KK; Lee IS; Magae J; Ando K; Kim CH; Chang YC
J Proteome Res; 2006 Oct; 5(10):2620-31. PubMed ID: 17022633
[TBL] [Abstract][Full Text] [Related]
14. Comparing SILAC and two-dimensional gel electrophoresis image analysis for profiling urokinase plasminogen activator signaling in ovarian cancer cells.
Uitto PM; Lance BK; Wood GR; Sherman J; Baker MS; Molloy MP
J Proteome Res; 2007 Jun; 6(6):2105-12. PubMed ID: 17472359
[TBL] [Abstract][Full Text] [Related]
15. Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.
Wu CC; Chen HC; Chen SJ; Liu HP; Hsieh YY; Yu CJ; Tang R; Hsieh LL; Yu JS; Chang YS
Proteomics; 2008 Jan; 8(2):316-32. PubMed ID: 18203259
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
17. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head.
Tan X; Cai D; Wu Y; Liu B; Rong L; Chen Z; Zhao Q
Transl Res; 2006 Sep; 148(3):114-9. PubMed ID: 16938648
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of secreted proteins of non-small cell lung cancer.
Huang LJ; Chen SX; Luo WJ; Jiang HH; Zhang PF; Yi H
Ai Zheng; 2006 Nov; 25(11):1361-7. PubMed ID: 17094902
[TBL] [Abstract][Full Text] [Related]
20. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis.
Sheng KH; Yao YC; Chuang SS; Wu H; Wu TF
Proteomics; 2006 Feb; 6(3):1058-65. PubMed ID: 16400682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
